PerkinElmer Inc. (PKI)
NYSE: PKI
· Real-Time Price · USD
115.24
-1.06 (-0.91%)
At close: May 15, 2023, 10:03 PM
PerkinElmer Revenue Breakdown
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Oct 4, 2020 | Jul 5, 2020 | Apr 5, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics Revenue | 354.39M | 324.37M | 739.91M | 383.13M | 377.84M | 73.68M | 214.46M | 199.01M | 200.18M | 186.39M | 265.97M | 308.78M | 145.67M | 49.11M | 44.83M | 43.83M | 42.59M | 42.82M | 45.95M | 43.97M | 41.33M | 40.87M | 40.45M | 37.53M | 36.69M | 36.12M | 33.8M |
| Diagnostics Revenue Growth | +9.25% | -56.16% | +93.12% | +1.40% | +412.82% | -65.64% | +7.76% | -0.59% | +7.40% | -29.92% | -13.87% | +111.98% | +196.60% | +9.56% | +2.28% | +2.90% | -0.52% | -6.82% | +4.50% | +6.39% | +1.12% | +1.05% | +7.77% | +2.29% | +1.58% | +6.87% | n/a |
| Life Sciences Revenue | 365.9M | 340.39M | 639.38M | 300.92M | 313.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Life Sciences Revenue Growth | +7.49% | -46.76% | +112.47% | -4.12% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Sep 29, 2024 | Jun 30, 2024 | Apr 1, 2018 |
|---|---|---|---|---|---|
| Americas Revenue | 323.58M | 304.63M | 302.32M | 307.78M | 157.49M |
| Americas Revenue Growth | +6.22% | +0.76% | -1.77% | +95.43% | n/a |
| Asia Revenue | 193.07M | 178.34M | 199.69M | 199.31M | 119.66M |
| Asia Revenue Growth | +8.26% | -10.69% | +0.19% | +66.57% | n/a |
| Europe Revenue | 203.63M | 181.79M | 182.04M | 184.59M | 119.37M |
| Europe Revenue Growth | +12.01% | -0.14% | -1.38% | +54.63% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Oct 4, 2020 | Jul 5, 2020 | Apr 5, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Oct 4, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 248.53M | 249.72M | 234.17M | 237.52M | 251.65M | 267.02M | 248.56M | 244.32M | 239.97M | 330.02M | 334.39M | 355.25M | 339.05M | 281.82M | 251.41M | 263.05M | 225.25M | 221.03M | 208.57M | 210.74M | 204.17M | 201.55M | 198.86M | 210.54M | 196.77M | 204.88M | 199.72M | 172.27M | 150.86M | 147.94M | 145.09M | 162.79M | 145.79M | 153.99M | 147.54M | 158.5M | 147.73M | 146.74M | 145.87M |
| Selling, General, and Administrative Revenue Growth | -0.48% | +6.64% | -1.41% | -5.61% | -5.76% | +7.43% | +1.73% | +1.82% | -27.29% | -1.31% | -5.87% | +4.78% | +20.31% | +12.10% | -4.43% | +16.78% | +1.91% | +5.97% | -1.03% | +3.22% | +1.30% | +1.36% | -5.55% | +7.00% | -3.96% | +2.58% | +15.94% | +14.19% | +1.97% | +1.96% | -10.87% | +11.66% | -5.33% | +4.37% | -6.91% | +7.30% | +0.67% | +0.60% | n/a |
| Research and Development Revenue | 53.27M | 53.6M | 28.36M | 49.14M | 48.13M | 57.25M | 56.69M | 54.54M | 53.52M | 73.35M | 76.61M | 80.32M | 68.61M | 65.82M | 60.22M | 56.82M | 50.13M | 49.52M | 48.91M | 47.64M | 45.38M | 48.34M | 47.98M | 51.97M | 48.85M | 47.2M | 45.98M | 37.67M | 34.89M | 33.56M | 33.29M | 32.93M | 33.17M | 35.01M | 33.78M | 30.03M | 31.09M | 32.68M | 32.12M |
| Research and Development Revenue Growth | -0.61% | +88.95% | -42.28% | +2.10% | -15.93% | +0.99% | +3.95% | +1.90% | -27.04% | -4.25% | -4.62% | +17.07% | +4.23% | +9.31% | +5.97% | +13.35% | +1.23% | +1.24% | +2.68% | +4.98% | -6.14% | +0.76% | -7.68% | +6.39% | +3.50% | +2.64% | +22.08% | +7.97% | +3.95% | +0.82% | +1.10% | -0.75% | -5.23% | +3.62% | +12.50% | -3.42% | -4.86% | +1.75% | n/a |